Connor Clark & Lunn Investment Management Ltd. Invests $19.28 Million in Humana Inc. $HUM

Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Humana Inc. (NYSE:HUM) in the 2nd quarter, Holdings Channel reports. The fund acquired 48,531 shares of the insurance provider’s stock, valued at approximately $19,277,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Montag A & Associates Inc. grew its stake in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after buying an additional 94 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Humana during the 2nd quarter valued at $26,000. Fideuram Asset Management Ireland dac bought a new stake in shares of Humana during the 4th quarter worth $27,000. Trust Co. of Vermont bought a new stake in shares of Humana during the 2nd quarter worth $28,000. Finally, Reflection Asset Management purchased a new position in Humana in the fourth quarter worth $29,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts recently commented on HUM shares. Mizuho increased their target price on Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a research note on Monday, June 8th. Bank of America raised Humana from a “neutral” rating to a “buy” rating and set a $500.00 price target for the company in a research note on Wednesday, July 29th. Evercore upgraded Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price objective for the company in a report on Wednesday, July 29th. Sanford C. Bernstein reiterated an “outperform” rating and set a $425.00 price objective on shares of Humana in a research report on Wednesday, June 3rd. Finally, Cantor Fitzgerald raised their price objective on Humana from $264.00 to $300.00 and gave the company a “neutral” rating in a report on Tuesday, July 7th. Fourteen analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Humana has an average rating of “Hold” and an average price target of $403.91.

Humana Stock Performance

NYSE:HUM opened at $388.92 on Wednesday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88. The firm has a market cap of $46.70 billion, a PE ratio of 36.79, a price-to-earnings-growth ratio of 2.20 and a beta of 0.72. The business has a 50 day moving average price of $383.88 and a 200-day moving average price of $285.00.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. During the same period in the previous year, the firm earned $6.27 earnings per share. The firm’s revenue for the quarter was up 26.2% on a year-over-year basis. Equities research analysts predict that Humana Inc. will post 9.12 earnings per share for the current year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.